CUV 1.60% $14.74 clinuvel pharmaceuticals limited

fda meeting then rise, page-3

  1. 680 Posts.
    FDA approval is not easy, and in EPT case its far from
    certain.
    Expect a selloff when they are rejected.
 
watchlist Created with Sketch. Add CUV (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.